Blog - Litchlab

EN

CN

{$ImageUrl,alt}

Blog

Home>Blog

Comprehensive Analysis of Liposome Types: Diversified Solutions for Vaccine Delivery

Comprehensive Analysis of Liposome Types: Diversified Solutions for Vaccine DeliveryLiposomes, as crucial carriers for vaccine delivery, possess unique structural and functional characteristics that enable them to meet the complex needs of various vaccines. Fr...

Breakthrough of Liposome Technology in Cancer Therapy: FDA Approval of Irinotecan Liposome for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma

Breakthrough of Liposome Technology in Cancer Therapy: FDA Approval of Irinotecan Liposome for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma In May 2024, the U.S. Food and Drug Administration (FDA) announced the approval of irinotecan lipos...

mRNA Vaccines and Lipid Nanoparticle Lyophilization Technology: Breakthroughs in Innovative Delivery Systems in Vaccine Development

mRNA Vaccines and Lipid Nanoparticle Lyophilization Technology: Breakthroughs in Innovative Delivery Systems in Vaccine Development Driven by the COVID-19 pandemic, mRNA vaccines and lipid nanoparticle (LNP) delivery systems have become key technologies i...

磁性纳米颗粒5.jpg

Litchlab Launches Innovative Targeted Drug Delivery Platform: Precision Treatment Through Surface-Modified Liposomes

January 2025 – Litchlab, a leading biotechnology company focused on liposome drug delivery technology, has announced the official launch of its groundbreaking targeted drug delivery platform. This platform leverages surface-modified liposomes to precisely targ...

纳米载体5.jpg

Litchlab: A Leader in Targeted Liposome Drug Delivery Technology

In the field of drug delivery, liposome technology has become a critical therapeutic tool, especially with its application in targeted drug delivery systems. As the demand for targeted therapies continues to rise, the potential of liposomes as drug carriers is...

更换4.jpg

A New Era in Delivery: Our Liposome Technology Supports the Future of Drug and Vaccine Development

A New Era in Delivery: Our Liposome Technology Supports the Future of Drug and Vaccine Development In the modern biopharmaceutical field, efficient delivery technology is a key factor in determining the success of treatments. Our company focuses on...

更换2.jpg

Breakthrough of Liposome Technology in Cancer Therapy: FDA Approval of Irinotecan Liposome for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma

Breakthrough of Liposome Technology in Cancer Therapy: FDA Approval of Irinotecan Liposome for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma In May 2024, the U.S. Food and Drug Administration (FDA) announced the approval of irinotecan lipos...

更改3.jpg

Key Role and Application Prospects of Liposomes in Vaccines

Key Role and Application Prospects of Liposomes in Vaccines In recent years, liposome technology has garnered significant attention in the vaccine field, particularly in the development of COVID-19 vaccines, where liposomes have served as a core technolo...

更换5.jpg

Breakthrough in New mRNA Vaccine Liposomes

Breakthrough in New mRNA Vaccine Liposomes In June 2024, BioTechPharma, a global leader in biopharmaceuticals, announced that its innovative mRNA vaccine liposome carrier has successfully entered the clinical trial phase. The vaccine, developed to target a nov...

上一页 1 2 下一页